Riskpilot← Back to searchSign inGet full accessBLUE SURGICAL ApS
APSActiveCVR 30198964Virumvej 64Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20075 employees
Revenue 2025
DKK 8,6M
-7% vs 2024
EBITDA margin
45.9%
-23% vs 2024
Equity ratio
47.6%
Financial strength
Net profit 2025
DKK 3M
-24% vs 2024
| Revenue | DKK 8,6M | -7% |
| EBITDA | DKK 4M | -23% |
| Net profit | DKK 3M | -24% |
| Total assets | DKK 12,1M | -15% |
| Equity | DKK 5,8M | -14% |
| Employees | 5 | — |
Legal name
BLUE SURGICAL ApS
CVR number
30198964
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. januar 2007
Share capital
DKK 125.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at sælge og distribuere hospitalsprodukter.
Address
Virumvej 64
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.870 | -2.463 | 2.391 | 1.888 | 2.671 | 3.023 | 3.039 | 4.202 | 4.841 | 5.768 | 6.291 | 8.154 | 9.275 | 8.619 |
| Staff expenses | -1.443 | -1.937 | -2.043 | -1.847 | -2.386 | -2.386 | -2.243 | -2.660 | -3.104 | -2.880 | -3.274 | -3.742 | -4.126 | -4.665 |
| EBITDA | 427 | -510 | 348 | 41 | 285 | 414 | 796 | 1.542 | 1.737 | 2.888 | 3.017 | 4.412 | 5.149 | 3.954 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 427 | -510 | 348 | 41 | 285 | 414 | 796 | 1.542 | 1.737 | 2.888 | 3.017 | 4.412 | 5.149 | 3.954 |
| Net financials | -2 | -9 | -3 | -22 | -25 | -16 | -20 | -14 | -23 | -22 | -16 | -42 | -10 | -132 |
| Profit before tax | 425 | -518 | 345 | 19 | 261 | 397 | 776 | 1.527 | 1.714 | 2.865 | 3.001 | 4.369 | 5.139 | 3.893 |
| Tax | 114 | -143 | 95 | 13 | 63 | 97 | 179 | 344 | 384 | 640 | 664 | 975 | 1.134 | 859 |
| Net profit | 311 | -375 | 250 | 6 | 198 | 301 | 597 | 1.183 | 1.331 | 2.225 | 2.337 | 3.394 | 4.004 | 3.034 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.838 | 2.786 | 1.560 | 2.527 | 3.221 | 3.596 | 3.887 | 5.857 | 6.699 | 7.723 | 9.463 | 10.360 | 14.183 | 12.113 |
| Equity | 825 | 900 | 1.054 | 754 | 833 | 1.032 | 1.509 | 2.572 | 3.403 | 4.828 | 4.952 | 6.122 | 6.733 | 5.763 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 339 | 402 | 635 | 664 | 1.018 | 1.135 | 859 |
| Short-term debt | 2.013 | -1.885 | 1.690 | 1.772 | 2.388 | 2.564 | 2.378 | 2.945 | 2.894 | 2.260 | 3.846 | 3.220 | 6.315 | 5.492 |
| Total debt | 2.013 | -1.885 | 1.690 | 1.772 | 2.388 | 2.564 | 2.378 | 3.285 | 3.296 | 2.895 | 4.510 | 4.238 | 7.450 | 6.350 |
EBITDA margin
45.9%
This company
15.8%
Market median
+191% vs market
20122025
Equity ratio
47.6%
This company
38.2%
Market median
+25% vs market
20122025
Return on equity
52.7%
This company
18.4%
Market median
+186% vs market
20122025
Net profit margin
35.2%
This company
8.1%
Market median
+335% vs market
20122025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20122025
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TV Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
polyneaus ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
polyneaus ApS
BLUE SURGICAL ApS Board members of BLUE SURGICAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Volder Andersen | Management | 0 companies |